Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (574)	11/11/2002 11:00:30 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 724

Margin 42.6%. (eom)

To: scaram(o)uche who wrote (574)	2/24/2003 9:25:48 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 724

>> Accounts payable and accrued expenses to 6.2M from 7.0M. Spit and shine quarter, current ratio to 5.1 from 12/31 of 3.6. << AP to 6.5M this quarter, current ratio to 4.9. Definitely a mediocre quarter at best, which is as good as I was hoping for. Margin for the quarter was 41.9%, smack in NBSC territory. Can someone tell me why the year-over-year increase in shares out is less than the 10% share dividend? TIA. Nice job for a tough quarter, great job on the year. Thank you, Freedman et al.!